GlassScriptPhysician profile
Brad Jay Jones
NPI 1639640436
$701.72
in general payments reported to CMS, 2019-2025
17 companies · $563 in 2025
The $563 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $114.67 | 2025 | Nuplazid |
| Novo Nordisk INC | $101.97 | 2021-2025 | Ozempic, Wegovy |
| Pfizer INC. | $87.40 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $81.28 | 2025 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.49 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $42.86 | 2021 | |
| Dexcom, INC. | $38.78 | 2021-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $28.21 | 2025 | |
| Nestle Healthcare Nutrition INC. | $24.91 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.82 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $19.71 | 2025 | Rexulti |
| Sanofi Pasteur INC. | $17.91 | 2025 | |
| Glaxosmithkline, LLC. | $17.74 | 2025 | Shingrix |
| Exact Sciences Corporation | $16.29 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $14.27 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.17 | 2025 | Kisunla |
| Takeda Pharmaceuticals U.S.A., INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.